TipRanks
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market
MGRX
Mangoceuticals, Inc.
RESEARCH TOOLSreports

Mangoceuticals, Inc. (MGRX) Income Statement

168 Followers

Mangoceuticals, Inc. Income Statement

Last quarter (Q2 2026), Mangoceuticals, Inc.'s total revenue was $68.76K, a decrease of -59.10% from the same quarter last year. In Q2, Mangoceuticals, Inc.'s net income was $-1.31M. See Mangoceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 456.02K$ 615.87K$ 731.49K$ 8.94K$ 0.00
Gross Profit
$ 250.39K$ 379.96K$ 431.50K$ 4.85K$ 0.00
Operating Expenses
$ 19.41M$ 8.35M$ 9.65M$ 2.00M$ 17.52K
Depreciation and Amortization
$ 1.72M$ 721.53K$ 24.89K$ 3.86K$ 0.00
EBITDA
$ -18.82M$ -7.96M$ -8.09M$ -1.99M$ -17.52K
Operating Income
$ -19.15M$ -7.97M$ -9.22M$ -1.99M$ -17.52K
Other Income/Expenses
$ -1.49M$ -735.00K$ 6.47K$ -6.47K$ -181.00
Pretax Income
$ -20.64M$ -8.71M$ -9.21M$ -2.00M$ -17.70K
Net Income
$ -20.64M$ -8.71M$ -9.21M$ -2.00M$ -17.70K
Per Share Metrics
Basic EPS
$ -2.05$ -4.40$ -6.45$ -1.73$ -0.02
Diluted EPS
$ -2.05$ -4.40$ -6.45$ -1.73$ -0.02
Weighted Average Shares Outstanding
 10.07M 1.98M 1.43M 1.15M 1.15M
Weighted Average Shares Outstanding (Diluted)
 10.07M 1.98M 1.43M 1.15M 1.15M
Currency in USD

Mangoceuticals, Inc. Earnings and Revenue History